Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain.
Obesity (Silver Spring). 2017 Apr;25(4):788-793. doi: 10.1002/oby.21796. Epub 2017 Mar 9.
To analyze the reference range of thyroid-stimulating hormone (TSH) in different BMI categories and its impact on the classification of hypothyroidism.
The study included 3,928 individuals free of thyroid disease (without previous thyroid disease, no interfering medications, TSH <10 µUI/mL and thyroid peroxidase antibodies [TPO Abs] <50 IU/mL) who participated in a national, cross-sectional, population-based study and were representative of the adult population of Spain. Data gathered included clinical and demographic characteristics, physical examination, and blood and urine sampling. TSH, free thyroxine, free triiodothyronine, and TPO Ab were analyzed by electrochemiluminescence (E170, Roche Diagnostics, Basel, Switzerland).
The reference range (p2.5-97.5) for TSH was estimated as 0.6 to 4.8 µUI/mL in the underweight category (BMI<20 kg/m ), 0.6 to 5.5 µUI/mL in the normal-weight category (BMI 20-24.9 kg/m ), 0.6 to 5.5 µUI/mL in the overweight category (BMI 25-29.9 kg/m ), 0.5 to 5.9 µUI/mL in the obesity category (BMI 30-39.9 kg/m ), and 0.7 to 7.5 µUI/mL in the morbid obesity category (BMI ≥40). By using the reference criteria for the normal-weight population, the prevalence of high TSH levels increased threefold in the morbid obesity category (P < 0.01).
Persons with morbid obesity might be inappropriately classified if the standard ranges of normality of TSH for the normal-weight population are applied to them.
分析不同 BMI 类别中促甲状腺激素(TSH)的参考范围及其对甲状腺功能减退分类的影响。
本研究纳入了 3928 名无甲状腺疾病(无既往甲状腺病史、无干扰药物、TSH<10µUI/mL 且甲状腺过氧化物酶抗体[TPOAb] <50IU/mL)的个体,他们参加了一项全国性的、横断面的、基于人群的研究,代表了西班牙的成年人口。收集的数据包括临床和人口统计学特征、体格检查以及血液和尿液采样。TSH、游离甲状腺素、游离三碘甲状腺原氨酸和 TPOAb 采用电化学发光法(E170,罗氏诊断公司,巴塞尔,瑞士)进行分析。
在体重不足(BMI<20kg/m )类别中,TSH 的参考范围(p2.5-97.5)估计为 0.6 至 4.8µUI/mL;在正常体重(BMI 20-24.9kg/m )类别中为 0.6 至 5.5µUI/mL;在超重(BMI 25-29.9kg/m )类别中为 0.6 至 5.5µUI/mL;在肥胖(BMI 30-39.9kg/m )类别中为 0.5 至 5.9µUI/mL;在病态肥胖(BMI ≥40)类别中为 0.7 至 7.5µUI/mL。使用正常体重人群的参考标准,病态肥胖人群中高 TSH 水平的患病率增加了三倍(P<0.01)。
如果将适用于正常体重人群的 TSH 正常范围标准应用于病态肥胖人群,可能会导致他们被不恰当地分类。